An autosomal dominant cardiac arrhythmia syndrome, ST Depression Syndrome, is caused by the de novo creation of a cardiomyocyte enhancer
Carin P. de Villiers, View ORCID ProfileDamien J. Downes, View ORCID ProfileAnuj Goel, Alistair T. Pagnamenta, Elizabeth Ormondroyd, Alexander J. Sparrow, Svanhild Nornes, Edoardo Giacopuzzi, Phalguni Rath, Ben Davies, View ORCID ProfileRon Schwessinger, Matthew E. Gosden, Robert A. Beagrie, Duncan Parkes, Rob Hastings, Stefano Lise, Silvia Salatino, Hannah Roberts, Maria Lopopolo, Carika Weldon, Amy Trebes, The WGS500 consortium, David Buck, Jenny C. Taylor, Charles Redwood, Edward Rowland, Dushen Tharmaratnam, Graham Stuart, Pier D. Lambiase, Sarah De Val, View ORCID ProfileJim R. Hughes, View ORCID ProfileHugh Watkins
doi: https://doi.org/10.1101/2024.08.20.24312115
Carin P. de Villiers
1Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Damien J. Downes
2MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Anuj Goel
1Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
3Centre for Human Genetics, University of Oxford, Oxford, UK
Alistair T. Pagnamenta
3Centre for Human Genetics, University of Oxford, Oxford, UK
Elizabeth Ormondroyd
1Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Alexander J. Sparrow
1Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Svanhild Nornes
4Ludwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford, UK
5Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK
Edoardo Giacopuzzi
3Centre for Human Genetics, University of Oxford, Oxford, UK
6Human Technopole, Milan, Italy
Phalguni Rath
3Centre for Human Genetics, University of Oxford, Oxford, UK
Ben Davies
3Centre for Human Genetics, University of Oxford, Oxford, UK
Ron Schwessinger
2MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
7MRC WIMM Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Matthew E. Gosden
2MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Robert A. Beagrie
3Centre for Human Genetics, University of Oxford, Oxford, UK
8Laboratory of Gene Regulation, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Duncan Parkes
3Centre for Human Genetics, University of Oxford, Oxford, UK
Rob Hastings
1Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Stefano Lise
3Centre for Human Genetics, University of Oxford, Oxford, UK
9University College London Cancer Institute, London, UK
Silvia Salatino
3Centre for Human Genetics, University of Oxford, Oxford, UK
Hannah Roberts
3Centre for Human Genetics, University of Oxford, Oxford, UK
Maria Lopopolo
3Centre for Human Genetics, University of Oxford, Oxford, UK
Carika Weldon
3Centre for Human Genetics, University of Oxford, Oxford, UK
Amy Trebes
3Centre for Human Genetics, University of Oxford, Oxford, UK
David Buck
3Centre for Human Genetics, University of Oxford, Oxford, UK
Jenny C. Taylor
3Centre for Human Genetics, University of Oxford, Oxford, UK
Charles Redwood
1Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Edward Rowland
11St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK and UCL Institute of Cardiovascular Science, University College London, London, UK
Dushen Tharmaratnam
12Royal Devon University Healthcare NHS Foundation Trust
Graham Stuart
13Bristol Heart Institute, Bristol, United Kingdom
Pier D. Lambiase
11St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK and UCL Institute of Cardiovascular Science, University College London, London, UK
Sarah De Val
4Ludwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford, UK
5Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK
Jim R. Hughes
2MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
7MRC WIMM Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Hugh Watkins
1Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
3Centre for Human Genetics, University of Oxford, Oxford, UK
Data Availability
All data produced in the present work are contained in the manuscript
Posted August 20, 2024.
An autosomal dominant cardiac arrhythmia syndrome, ST Depression Syndrome, is caused by the de novo creation of a cardiomyocyte enhancer
Carin P. de Villiers, Damien J. Downes, Anuj Goel, Alistair T. Pagnamenta, Elizabeth Ormondroyd, Alexander J. Sparrow, Svanhild Nornes, Edoardo Giacopuzzi, Phalguni Rath, Ben Davies, Ron Schwessinger, Matthew E. Gosden, Robert A. Beagrie, Duncan Parkes, Rob Hastings, Stefano Lise, Silvia Salatino, Hannah Roberts, Maria Lopopolo, Carika Weldon, Amy Trebes, The WGS500 consortium, David Buck, Jenny C. Taylor, Charles Redwood, Edward Rowland, Dushen Tharmaratnam, Graham Stuart, Pier D. Lambiase, Sarah De Val, Jim R. Hughes, Hugh Watkins
medRxiv 2024.08.20.24312115; doi: https://doi.org/10.1101/2024.08.20.24312115
An autosomal dominant cardiac arrhythmia syndrome, ST Depression Syndrome, is caused by the de novo creation of a cardiomyocyte enhancer
Carin P. de Villiers, Damien J. Downes, Anuj Goel, Alistair T. Pagnamenta, Elizabeth Ormondroyd, Alexander J. Sparrow, Svanhild Nornes, Edoardo Giacopuzzi, Phalguni Rath, Ben Davies, Ron Schwessinger, Matthew E. Gosden, Robert A. Beagrie, Duncan Parkes, Rob Hastings, Stefano Lise, Silvia Salatino, Hannah Roberts, Maria Lopopolo, Carika Weldon, Amy Trebes, The WGS500 consortium, David Buck, Jenny C. Taylor, Charles Redwood, Edward Rowland, Dushen Tharmaratnam, Graham Stuart, Pier D. Lambiase, Sarah De Val, Jim R. Hughes, Hugh Watkins
medRxiv 2024.08.20.24312115; doi: https://doi.org/10.1101/2024.08.20.24312115
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2944)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12750)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4586)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2918)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4359)
- Nursing (236)
- Nutrition (639)
- Oncology (2271)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (496)
- Public and Global Health (6944)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)